a public good project by the
Synthesis
Company
of California

© 2026

Eisuke Mekada | doi.page

0 works0 citations0 h-index

Eisuke Mekada

Publications by Year

Research Areas

Toxin Mechanisms and Immunotoxins, HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Transgenic Plants and Applications, Cell Adhesion Molecules Research

Most-Cited Works

→ One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell(1978)753 cited
→ Requirement of CD9 on the Egg Plasma Membrane for Fertilization(2000)685 cited
→ Diphtheria toxin receptor–mediated conditional and targeted cell ablation in transgenic mice(2001)507 cited
→ Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function(2003)340 cited
→ Diphtheria Toxin Binds to the Epidermal Growth Factor (EGF)-like Domain of Human Heparin-binding EGF-like Growth Factor/Diphtheria Toxin Receptor and Inhibits Specifically Its Mitogenic Activity(1995)305 cited
→ Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing(2005)297 cited

→ The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor.(1995)

295 cited

→ Phorbol ester induces the rapid processing of cell surface heparin-binding EGF-like growth factor: conversion from juxtacrine to paracrine growth factor activity.(1995)268 cited

→ Heparin-binding EGF-like growth factor, which acts as the diphtheria toxin receptor, forms a complex with membrane protein DRAP27/CD9, which up-regulates functional receptors and diphtheria toxin sensitivity.(1994)265 cited

→ Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites.(1995)246 cited